Cbr-lin-11

Caenorhabditis briggsae

Predicted to enable DNA binding activity. Is an ortholog of C. elegans lin-11. In C. elegans, lin-11 is involved in several processes, including axonal fasciculation; egg-laying behavior; and positive regulation of vulval development.

Cbr-lin-38

Caenorhabditis briggsae

Is an ortholog of C. elegans lin-38. In C. elegans, lin-38 is involved in negative regulation of vulval development.

Cbr-lin-65

Caenorhabditis briggsae

Is an ortholog of C. elegans lin-65. In C. elegans, lin-65 is involved in chromatin remodeling and mitochondrial unfolded protein response.

Cbr-lin-33

Caenorhabditis briggsae

Is an ortholog of C. elegans lin-33.

Cbr-lin-8

Caenorhabditis briggsae

Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8. Is an ortholog of C. elegans lin-8. In C. elegans, lin-8 is involved in negative regulation of vulval development.

Cbr-lin-25

Caenorhabditis briggsae

Is an ortholog of C. elegans lin-25. In C. elegans, lin-25 is involved in defense response to Gram-positive bacterium and vulval development.

Cbr-lin-66

Caenorhabditis briggsae

Is an ortholog of C. elegans lin-66. In C. elegans, lin-66 is involved in negative regulation of gene expression and regulation of development, heterochronic.

Cbr-lin-46

Caenorhabditis briggsae

Predicted to be involved in molybdopterin cofactor biosynthetic process. Is an ortholog of C. elegans lin-46. In C. elegans, lin-46 is involved in regulation of development, heterochronic.

Cbr-lin-54

Caenorhabditis briggsae

Is predicted to encode a protein with the following domains: Lin-54 family; Tesmin/TSO1-like CXC domain; CRC domain; and Tesmin/TSO1-like CXC domain, cysteine-rich domain. Is an ortholog of C. elegans lin-54. In C. elegans, lin-54 is involved in negative regulation of vulval development.

Cbr-lin-26

Caenorhabditis briggsae

Is an ortholog of C. elegans lin-26. In C. elegans, lin-26 is involved in several processes, including positive regulation of transcription by RNA polymerase II; tissue development; and vulval development.